Heterocyclic lactam compounds

Organic compounds -- part of the class 532-570 series – Organic compounds – Four or more ring nitrogens in the bicyclo ring system

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546 83, C07D23970, C07D47104

Patent

active

049636774

ABSTRACT:
A compound of the formula ##STR1## and pharmaceutically acceptable salts thereof, in which A is --N.dbd.N--NH--, --X--C(R.sub.2).dbd.N--, --N.dbd.C(R.sub.2)--X--, --X--C(R.sub.2)--CH(R.sub.2).dbd.N-- or --N.dbd.C(R.sub.2)--CH(R.sub.2)--X--, wherein X is sulphur, oxygen or nitrogen and R.sub.2 is provided that where two R.sub.2 -groups are present in the A group one of the R.sub.2 groups is hydrogen, amino, substituted amino, C.sub.1-6 alkyl, substituted acylamino or one of the following groups: ##STR2## wherein R.sub.a is hydrogen, amino, substituted amino, C.sub.1-6 alkoxy, heterocyclic five membered ring or --NHCOR', wherein R' is C.sub.1-6 alkyl, aryl or heterocyclic five membered ring, R.sub.b is hydrogen, C.sub.1-6 alkoxy, C.sub.1-6 alkylthio or hydroxy, R.sub.c is hydrogen, C.sub.1-6 alkyl or oxygen and R.sub.d is C.sub.1-6 alkyl or oxygen, R.sub.e is hydrogen, hydroxy or C.sub.1-6 alkoxy, R.sub.f is C.sub.1-6 alkyl, provided that where two R.sub.2 -groups are present in the A group, one of the R.sub.2 groups is hydrogen; B is --(CH.sub.2).sub.m --C(R.sub.3 R.sub.4)--(CH.sub.2).sub.n --, --C(R.sub.3).dbd.CH--, --CH.dbd.C(R.sub.3)--, --O--[C(R.sub.3 R.sub.4)].sub.n --, --[C(R.sub.3 R.sub.4)].sub.n --O--, --S--[C(R.sub.3 R.sub.4)].sub.n -- or --[C(R.sub.3 R.sub.4)].sub.n --S-- wherein R.sub.3 and R.sub.4, which can be independently the same or different, are hydrogen, C1-.sub.6 alkyl, aryl (preferably phenyl) or pyridyl and m and n are independently zero or 1; D is either oxygen or sulphur; the two R-groups are indepenently hydrogen, C.sub.1-6 alkoxy, C.sub.1-6 alkyl, amino, acylamino or substituted acylamino, nitro, halogen, cyano, aldehyde, carboxy, carbamoyl; R.sub.1 is a hydrogen or C.sub.1-6 alkyl or R and R.sub.1 form together a fused 6-membered heterocyclic ring. The compound is effective in the treatment of congestive heart failure.

REFERENCES:
patent: 3714170 (1973-01-01), Dohmori et al.
patent: 3954775 (1976-05-01), Agui et al.
patent: 4522947 (1985-06-01), Musser et al.
patent: 4666923 (1987-05-01), Holck et al.
patent: 4695567 (1987-09-01), Mertens et al.
patent: 4698346 (1987-10-01), Musser et al.
patent: 4710510 (1987-12-01), Mertens et al.
patent: 4730003 (1988-03-01), von der Saal et al.
Chemical Abstracts, vol. 106, No. 13, 30th Mar. 1987, p. 649, column 1, D. R. Shridhar et al., "Synthesis and Anthelmintic Activity of Substituted Imidazo(4,5-g)-1,4-Benzoxazin-3-Ones. . .".

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Heterocyclic lactam compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic lactam compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic lactam compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-850732

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.